Q4 2025 Accendra Health Inc Earnings Call Transcript
Key Points
- Accendra Health Inc (ACH) has access to approximately 300 million Americans through expansive payer relationships, positioning it as a leader in home-based care for chronic conditions.
- The company has high brand recognition and customer support through its primary brands, Byram and Apria, validated by Net Promoter Scores exceeding industry averages.
- Accendra Health Inc (ACH) is leveraging technology and automation to improve customer experience and reduce costs, including the launch of the MyApria app to enhance operational efficiency.
- The company completed the sale of its former products and healthcare services business, allowing it to focus on strengthening core home-based care businesses and improving its margin profile.
- Accendra Health Inc (ACH) has a strong cash generation profile, with $135 million generated from operating activities in the fourth quarter of 2025, and a commitment to debt reduction with $65 million paid down from ordinary free cash flow.
- The loss of a large commercial payer is expected to impact revenue significantly, with a $300 million reduction anticipated in 2026 compared to 2025.
- Fourth-quarter adjusted EBITDA decreased to $90 million from $102.5 million in the previous year, affected by lower payment prices, inflationary product cost increases, and stranded costs.
- The company faces challenges with manufacturer cost increases and inflation, which are outpacing pricing growth in certain categories.
- Accendra Health Inc (ACH) is undergoing a transition period with the divestiture of its former business, which includes addressing stranded costs and optimizing its capital structure.
- The company anticipates a weaker first quarter in 2026, with only 40% of adjusted EBITDA expected in the first half of the year due to cost reduction ramping and the impact of the large commercial payer loss.
Hello. Good day, and thank you for standing by. Welcome to the Accendra Health fourth-quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Will Parrish, Vice President, Strategy, Corporate Development, and Investor Relations.
Thank you, operator. Good afternoon, everyone, and welcome to Accendra Health's fourth-quarter earnings call. Our comments on the call will be focused on the financial results of the fourth quarter of 2025, all of which are included in today's press release. The press release, along with the fourth quarter 2025 supplemental slides, are posted on the Investor Relations section of our website.
Please note that during this call, we will make forward-looking statements that reflect the current views of Accendra Health about our business, financial performance, and future events
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

